Related Experiment Video
Updated: Oct 21, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association of blood pressure with cardiovascular outcome and mortality: results from the KNOW-CKD study
Jee Young Lee1, Jung Tak Park1, Young Su Joo1
1Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea.
Insights
Optimal blood pressure control is crucial for patients with chronic kidney disease (CKD). This study found a U-shaped association between systolic blood pressure (SBP) and adverse outcomes, indicating risks at both low and high SBP levels.
Area of Science:
- Nephrology
- Cardiology
- Clinical Epidemiology
Background:
- Optimal blood pressure (BP) management is vital for reducing cardiovascular events (CVEs) and mortality in chronic kidney disease (CKD) patients.
- Understanding the precise BP targets is critical for effective therapeutic strategies in CKD.
Purpose of the Study:
- To investigate the association between systolic blood pressure (SBP) levels and the risk of adverse cardiovascular outcomes and all-cause mortality in patients with CKD.
- To identify the optimal SBP range for improving clinical outcomes in the CKD population.
Main Methods:
- Analysis of 2226 participants from the KoreaN cohort study for Outcome in patients With CKD (KNOW-CKD).
- Systolic blood pressure (SBP) was categorized into five levels: <110, 110-119, 120-129, 130-139, and ≥140 mmHg.
- Marginal structural models (MSMs) were employed using averaged and most recent time-updated SBPs to assess the primary endpoint (composite of all-cause death or incident CVEs).
Main Results:
- A U-shaped relationship was observed between averaged SBP and the primary composite outcome.
- Compared to SBP of 110-119 mmHg, hazard ratios (95% CI) for SBP <110 mmHg were 2.47 (1.48-4.11), and for SBP ≥140 mmHg were 2.19 (1.19-4.01).
- Similar findings were noted when using the most recent time-updated SBP.
Conclusions:
- A U-shaped association exists between SBP and adverse clinical outcomes in Korean patients with CKD.
- The findings emphasize the importance of BP control in CKD, suggesting that SBP <110 mmHg may pose a significant risk.
- Further research is warranted to establish precise BP management guidelines for CKD patients, considering both hypotension and hypertension.
Background:
Optimal blood pressure (BP) control is a major therapeutic strategy to reduce adverse cardiovascular events (CVEs) and mortality in patients with chronic kidney disease (CKD). We studied the association of BP with adverse cardiovascular outcome and all-cause death in patients with CKD.
Methods:
Among 2238 participants from the KoreaN cohort study for Outcome in patients With CKD (KNOW-CKD), 2226 patients with baseline BP measurements were enrolled. The main predictor was systolic BP (SBP) categorized by five levels: <110, 110-119, 120-129, 130-139 and ≥140 mmHg. The primary endpoint was a composite outcome of all-cause death or incident CVEs. We primarily used marginal structural models (MSMs) using averaged and the most recent time-updated SBPs.
Results:
During the follow-up of 10 233.79 person-years (median 4.60 years), the primary composite outcome occurred in 240 (10.8%) participants, with a corresponding incidence rate of 23.5 [95% confidence interval (CI) 20.7-26.6]/1000 patient-years. MSMs with averaged SBP showed a U-shaped relationship with the primary outcome. Compared with time-updated SBP of 110-119 mmHg, hazard ratios (95% CI) for <110, 120-129, 130-139 and ≥140 mmHg were 2.47 (1.48-4.11), 1.29 (0.80-2.08), 2.15 (1.26-3.69) and 2.19 (1.19-4.01), respectively. MSMs with the most recent SBP also showed similar findings.
Conclusions:
In Korean patients with CKD, there was a U-shaped association of SBP with the risk of adverse clinical outcomes. Our findings highlight the importance of BP control and suggest a potential hazard of SBP <110 mmHg.
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Errors occurring during blood pressure monitoring
Several factors...
Hypertension and Regulation of Blood Pressure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Measurement of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies

